Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA

por Ferreira, Alberto, Sagkriotis, Alexandros, Olson, Melvin, Lu, Jingsong, Makin, Charles, Milnes, Fran
Publicado 2015

A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom

por Johnston, Robert L., Carius, Hans-Joachim, Skelly, Adrian, Ferreira, Alberto, Milnes, Fran, Mitchell, Paul
Publicado 2017